证券代码：301580 证券简称：爱迪特 | --- | --- | |-------|-------------------------------------------------------------| | | | | | 2. 公司存货周转水平上升的原因是什么？ 答： | | | 存货增加系阶段性的波动导致。首先，公司今年更新 ERP | | | 系统，上线 SAP 系统对公司海内外分支做高效管理，在此期间 | | | 增加了安全库存储备以保障系统切换期间订单的及时交付；第 | | | 二，针对个别区域的发展需求，公司对海外仓适当增加了一定 | | | 存货。 | | | 3. 公司设立美国、德国子公司负责欧美核心市场的运营，但日、 | | | 韩两国相比欧美市场规模较小却设立子公司基于何种考虑？ | | | 答： | | | 日、韩两国口腔市场发展较为成熟，在国际上认可度较高， | | | 公司在日韩设立子公司进行本土化运营旨在提升公司产品竞 | | | | | | 争力和品牌知名度。 | | | 4. 公司沃兰种植体销售情况如何？ | | | 答： | | | 公司收购沃兰后渠道整合及市场拓展 ...

证券代码：301580 证券简称：爱迪特 爱迪特（秦皇岛）科技股份有限公司投资者关系活动记录表 编号：2024-013 | --- | --- | --- | |-----------------------------|------------------------------|------------------------------------------------------------------------------------------------------------------| | | | | | | □特定对象调研 | ☑ 分析师会议 | | | | □媒体采访 □业绩说明会 | | 投资者关系 活动类别 | □新闻发布会 | □路演活动 | | | □现场参观 | | | | □其他 | （请文字说明其他活动内容） | | | 长城基金-谭小兵；平安养老 | - 邵瑾良；国泰基金-戴计辉；浦银 | | | 安盛 - | 徐博；德邦-曾叙衡；招银理财-熊超逸；上海东方证券- | | 参与单位名称 | | 刘中群、邹秉昂；上海肇万-李大瑞；广发-王瑞冬；银河-方伟； | | 及 ...

爱迪特（秦皇岛） 科技股份有限公司投资者关系活动记录表 证券代码：301580 证券简称：爱迪特 编号：2024-012 | --- | --- | --- | --- | |-----------------------------|-----------------------------------------|---------------------------------------------------------------------------------------------------------------|------------------| | | □特定对象调研 | ☑ 分析师会议 | | | | □媒体采访 □业绩说明会 | | | | 投资者关系 活动类别 | □新闻发布会 □路演活动 | | | | | □现场参观 | | | | | □其他 | （请文字说明其他活动内容） | | | 参与单位名称 及人员姓名 | | 华泰资产、华夏基金、招商基金、奥博资本、创金合信、前海 人寿、安信基金、理成资产、睿亿投资、招商资管香港、万和 | | | 时间 2024 | 年 ...

证券代码：301580 证券简称：爱迪特 爱迪特（秦皇岛） 科技股份有限公司投资者关系活动记录表 | --- | --- | --- | --- | |-----------------------------|---------------------------------|----------------------------|--------------------------------------------------------| | | | | 编号： 2024-011 | | | ☑ 特定对象调研 | □分析师会议 | | | | □媒体采访 □业绩说明会 | | | | 投资者关系 活动类别 | □新闻发布会 □路演活动 | | | | | □现场参观 | | | | | □其他 | （请文字说明其他活动内容） | | | 参与单位名称 及人员姓名 | 南方基金—蔡强 易方达基金—余欣鑫 | | | | 时间 2024 | 年 11 月 7 日 | | | | 地点 线上会议 | | | | | 上市公司接待 人员姓名 | 董事会秘书 郜雨 | | | | | | | | | | 投资 ...

证券代码：301580 证券简称：爱迪特 爱迪特（秦皇岛） 科技股份有限公司投资者关系活动记录表 编号：2024-010 | --- | --- | --- | |-----------------------|----------------------------|----------------------------------------------------------------------------------------| | | | | | | ☑ 特定对象调研 | □分析师会议 | | | □媒体采访 □业绩说明会 | | | 投资者关系 活动类别 | □新闻发布会 □路演活动 | | | | □现场参观 | | | | ☑ 其他 | （请文字说明其他活动内容） | | 参与单位名称 | | 招商医药—张语馨；长城基金—龙宇飞；工银瑞信—丁洋、谭 | | 及人员姓名 | | 冬寒；建信基金—张剑姝；兴业证券—董晓洁；众安保险—冯 航；合众资产—王浩；华夏基金—张太立 | | 时间 2024 | 年 10 月 31 日、 | 2024 年 11 月 1 日 | | | | | | 地点 ...

证券代码：301580 证券简称：爱迪特 爱迪特（秦皇岛） 科技股份有限公司投资者关系活动记录表 编号：2024-009 | --- | --- | --- | --- | --- | --- | |--------------------------|--------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------|-------|----------------| | | | | | | | | | □特定对象调研 □媒体采访 | □分析师会议 ☑ 业绩说明会 | | | | | 投资者关系 活动类别 | □新闻发布会 □路演 ...

Revenue and Profit - Revenue for the third quarter was RMB 226.7 million, a 9.54% increase year-over-year[2] - Net profit attributable to shareholders was RMB 34.3 million, a decrease of 2.88% compared to the same period last year[2] - Total revenue for the period reached 641,129,724.80 yuan, compared to 561,953,911.99 yuan in the previous period[17] - Net profit attributable to the parent company's owners rose to 528,136,598.92 yuan, up from 417,038,497.78 yuan[16] - Net profit attributable to parent company shareholders increased to RMB 111.1 million, up from RMB 98.6 million in the previous period[18] - Basic earnings per share increased to RMB 1.75, up from RMB 1.73 in the previous period[19] Assets and Liabilities - Total assets increased by 75.69% to RMB 2.27 billion, primarily due to the company's IPO proceeds[2] - Total assets increased to 2,269,388,731.70 yuan, up from 1,291,720,904.45 yuan at the beginning of the period[14][15][16] - Accounts receivable increased by 55.85% to RMB 199.5 million, driven by sales growth[5] - Inventory surged by 73.84% to RMB 179.5 million, mainly due to acquisitions[5] - Intangible assets grew by 1146.82% to RMB 93.4 million, driven by acquisitions and new industrial park land purchases[5] - Accounts receivable grew to 199,453,703.88 yuan, up from 127,978,981.41 yuan[14] - Inventory increased to 179,488,700.55 yuan, compared to 103,248,377.86 yuan at the beginning of the period[14] - Total liabilities rose to 261,083,752.46 yuan, up from 212,195,940.94 yuan[15] - Equity attributable to the parent company's owners increased to 1,952,367,480.64 yuan, up from 1,071,142,657.12 yuan[16] Cash Flow - Investment activities cash flow decreased by 63.38%, primarily due to acquisitions and new industrial park land purchases[8] - Financing activities cash flow surged by 72271.96%, mainly due to the IPO proceeds[8] - Operating cash flow increased to RMB 60.1 million, compared to RMB 47.2 million in the previous period[20] - Investment cash flow increased to RMB 59.4 million, compared to RMB 162.2 million in the previous period[22] - Financing cash flow increased significantly to RMB 771.1 million, compared to a negative RMB 1.1 million in the previous period[22] - Total cash and cash equivalents at the end of the period reached RMB 1.45 billion, up from RMB 462.1 million in the previous period[22] - Cash and cash equivalents surged to 1,447,937,535.54 yuan, compared to 558,155,826.76 yuan at the beginning of the period[14] - Cash received from tax refunds decreased to RMB 2.2 million, down from RMB 2.4 million in the previous period[20] - Cash paid for employee compensation increased to RMB 134.1 million, up from RMB 108.1 million in the previous period[20] - Cash paid for construction of fixed assets and intangible assets increased to RMB 72.8 million, up from RMB 24.8 million in the previous period[20] Expenses - Sales expenses increased by 33.28% to RMB 131.2 million, due to increased brand building and sales personnel[7] - R&D expenses increased to 33,002,325.33 yuan, up from 28,855,808.62 yuan in the previous period[17] - Sales expenses grew to 131,211,299.02 yuan, compared to 98,451,416.17 yuan in the previous period[17] Shareholders and Equity - The total number of ordinary shareholders at the end of the reporting period is 13,703[9] - The top shareholder, Tianjin Yuanyi Enterprise Management Consulting Center (Limited Partnership), holds 17.91% of the shares, amounting to 13,630,000 shares[9] - Tianjin Wendi Enterprise Management Consulting Center (Limited Partnership) holds 10.99% of the shares, totaling 8,363,918 shares[9] - Kangtuo Limited, an overseas legal entity, holds 7.51% of the shares, equivalent to 5,713,534 shares[9] - Schroders Capital Private Equity Asia Hong Kong I Limited holds 6.53% of the shares, amounting to 4,968,290 shares[9] - Suzhou Junlian Xinkang Venture Capital Partnership (Limited Partnership) holds 5.22% of the shares, totaling 3,974,632 shares[9] - ASP Hero SPV Limited holds 4.24% of the shares, equivalent to 3,229,389 shares[9] - CICC Qichen (Suzhou) Emerging Industry Equity Investment Fund Partnership (Limited Partnership) holds 3.54% of the shares, amounting to 2,696,128 shares[9] - Tianjin Jieying Enterprise Management Consulting Center (Limited Partnership) holds 3.52% of the shares, totaling 2,682,900 shares[11] - The total restricted shares at the end of the period amount to 58,069,900 shares[13] Sales and Revenue - Sales revenue from goods and services increased to RMB 618.6 million, up from RMB 546.4 million in the previous period[20]

爱迪特（秦皇岛） 科技股份有限公司投资者关系活动记录表 证券代码：301580 证券简称：爱迪特 | --- | --- | --- | --- | |------------------------|-----------------------|-----------------------------------------------------------------------------------------------|-----------------| | | | | 编号： 2024-008 | | | ☑ 特定对象调研 | □分析师会议 | | | 投资者关系 | □媒体采访 □业绩说明会 | | | | 活动类别 | □新闻发布会 □路演活动 | | | | | □现场参观 | | | | | □其他 | （请文字说明其他活动内容） | | | | 东方红医疗—刘中群 | | | | 参与单位名称 | 中信建投—张玉龙 | | | | 及人员姓名 | 西部证券—陆伏崴 | | | | | 中信医药—徐嘉琪 | | | | 时间 2024 | 年 9 月 27 日 | | | | | ...

爱迪特（秦皇岛） 科技股份有限公司投资者关系活动记录表 证券代码：301580 证券简称：爱迪特 | --- | --- | --- | --- | |-----------------------------|----------------------------------|----------------------------------------------------------|-----------------| | | | | 编号： 2024-007 | | | ☑ 特定对象调研 | □分析师会议 | | | | □媒体采访 □业绩说明会 | | | | 投资者关系 活动类别 | □新闻发布会 □路演活动 | | | | | □现场参观 | | | | | □其他 | （请文字说明其他活动内容） | | | 参与单位名称 及人员姓名 | 国联基金—刘柏川 | | | | | 民生医药—乐妍希 | | | | 时间 2024 | 年 9 月 23 日 | | | | 地点 腾讯会议 上市公司接待 | | | | | 人员姓名 | 董事会秘书 郜雨 | | | | | 投资者问答主要内容： ...

证券代码：301580 证券简称：爱迪特 爱迪特（秦皇岛） 科技股份有限公司投资者关系活动记录表 | --- | --- | --- | --- | --- | |-----------------------------|---------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------|--------|--------------| | | | | 编号： | 2024-006 | | | □特定对象调研 | □分析师会议 | | | | 投资者关系 | □媒体采访 □业绩说明会 | | | | | 活动类别 | □新闻发布会 | ☑ 路演活动 | | | | | □现场参观 | | | | | | □其他 | （请文字说明其他活 ...